Skip to content

Evaluating the Efficacy of Vishvadi Kwath in Managing Primary Dysmenorrhea (Udavartini Yonivyapad): A Clinical Study

A Clinical study to evaluate the effect of Vishwadi Kwath in Udavartini Yonivyapad (Primary Dysmenorrhea) - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/09/073971
Enrollment
40
Registered
2024-09-17
Start date
Unknown
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N944- Primary dysmenorrhea

Interventions

None listed

Sponsors

Shivani Sharma
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Signs and Symptoms of Primary Dysmenorrhea for more than 2 menstrual cycles. Age between 16 to 25 years Both Married (Nulliparous) and Unmarried. Regular menstrual cycle (21 to 35 days). Women with moderate to severe pain ( more than 5 in WaLIDD Score).

Exclusion criteria

Exclusion criteria: Excessive bleeding due to (Anatomical structural anomalies like Endometriosis, Adenomyosis, Uterine fibroids, endometrial polyp). Use of intrauterine contraceptive devices or oral contraceptive pills. Women with mild pain (less than 5 in WaLIDD Score). Diagnosed case of Systemic diseases (DM, HTN).

Design outcomes

Primary

MeasureTime frame
Reduction in the severity and duration of menstrual pain in participants with primary dysmenorrhea, as measured by a standardized pain scale over three consecutive menstrual cyclesTimepoint: 10 days

Secondary

MeasureTime frame
Improvement in Quality of Life: Assessed using a validated quality of life questionnaire specific to menstrual health. Reduction in Use of Pain Medication: Measured by the decrease in the frequency & dosage of pain relief medications taken by participants. Menstrual Cycle Regularity: Evaluated by tracking changes in the regularity & duration of menstrual cycles over the study period. Adverse Effects: Monitoring & recording any adverse effects or side effects experienced by participants during the study. Overall Satisfaction: Participant satisfaction with the treatment, measured through a post-treatment survey.Timepoint: 10 days

Countries

India

Contacts

Public ContactShivani Sharma

Sri Jayendra Saraswathi Ayurveda College and Hospital, Chennai

drlrathnakar@sjsach.org.in9840340826

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026